301156 美农生物
已收盘 01-06 15:00:00
资讯
新帖
简况
美农生物(301156)披露关于变更持续督导保荐代表人的公告,1月5日股价上涨1.77%
证券之星 · 01-05 18:34
美农生物(301156)披露关于变更持续督导保荐代表人的公告,1月5日股价上涨1.77%
每周股票复盘:美农生物(301156)拟每10股派1元
证券之星 · 01-03
每周股票复盘:美农生物(301156)拟每10股派1元
美农生物最新公告:股东全裕拟减持不超1%股份
证券之星 · 2025-12-30
美农生物最新公告:股东全裕拟减持不超1%股份
美农生物2025年中期拟每10股派现1元,股权登记日为2026年1月6日
中金财经 · 2025-12-29
美农生物2025年中期拟每10股派现1元,股权登记日为2026年1月6日
美农生物(301156)1388.18万股限售股将于12月17日解禁,占总股本9.86%
证券之星 · 2025-12-17
美农生物(301156)1388.18万股限售股将于12月17日解禁,占总股本9.86%
美农生物(301156.SZ)超5500万股限售股将解禁,实际可流通约1388万股
中金财经 · 2025-12-12
美农生物(301156.SZ)超5500万股限售股将解禁,实际可流通约1388万股
美农生物:截至2025年9月30日股东人数合计为10,420户
证券之星 · 2025-11-28
美农生物:截至2025年9月30日股东人数合计为10,420户
美农生物(301156)披露关于变更持续督导保荐代表人的公告,11月24日股价上涨1.38%
证券之星 · 2025-11-24
美农生物(301156)披露关于变更持续督导保荐代表人的公告,11月24日股价上涨1.38%
美农生物:公司产品应用于水产养殖领域
证券之星 · 2025-11-21
美农生物:公司产品应用于水产养殖领域
美农生物(301156)披露2025年中期利润分配方案,11月12日股价下跌0.83%
证券之星 · 2025-11-12
美农生物(301156)披露2025年中期利润分配方案,11月12日股价下跌0.83%
美农生物:探索非粮蛋白原料酶解技术
证券之星 · 2025-11-06
美农生物:探索非粮蛋白原料酶解技术
美农生物(301156)2025年三季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 2025-10-29
美农生物(301156)2025年三季报简析:营收净利润同比双双增长,盈利能力上升
图解美农生物三季报:第三季度单季净利润同比增长49.67%
证券之星 · 2025-10-27
图解美农生物三季报:第三季度单季净利润同比增长49.67%
美农生物(301156)9月30日股东户数1.04万户,较上期减少17.92%
证券之星 · 2025-10-27
美农生物(301156)9月30日股东户数1.04万户,较上期减少17.92%
股市必读:10月23日美农生物发布公告,股东减持104.92万股
证券之星 · 2025-10-24
股市必读:10月23日美农生物发布公告,股东减持104.92万股
美农生物控股股东一致行动人提前终止减持计划
中金财经 · 2025-10-23
美农生物控股股东一致行动人提前终止减持计划
股市必读:美农生物(301156)9月25日董秘有最新回复
证券之星 · 2025-09-26
股市必读:美农生物(301156)9月25日董秘有最新回复
美农生物:暂不涉及疫苗研发生产
证券之星 · 2025-09-25
美农生物:暂不涉及疫苗研发生产
美农生物:9月17日高管熊英减持股份合计15.01万股
证券之星 · 2025-09-18
美农生物:9月17日高管熊英减持股份合计15.01万股
美农生物:9月16日高管熊英减持股份合计18.3万股
证券之星 · 2025-09-17
美农生物:9月16日高管熊英减持股份合计18.3万股
公司概况
公司名称:
上海美农生物科技股份有限公司
所属行业:
食品制造业
上市日期:
2022-06-17
主营业务:
上海美农生物科技股份有限公司的主营业务是饲料添加剂、酶解蛋白饲料原料的研发、生产和销售。公司的主要产品是饲料添加剂、酶解蛋白饲料。上海美农是中国饲料行业协会会员单位、上海市饲料兽行业协会会长单位,持续获得“上海市高新技术企业”“上海市‘专精特新’中小企业”“上海市守合同重信用标杆企业”等荣誉,曾被评为“2020年三十家优秀创新ꞝ饲料企业”“2023年农业产业化嘉定区重点龙头企业”“上海嘉定区农业科技企业”,“美农”商标曾连续多年被评定为“上海市著名商标”。
发行价格:
23.48
{"stockData":{"symbol":"301156","market":"SZ","secType":"STK","nameCN":"美农生物","latestPrice":17.9,"timestamp":1767682983000,"preClose":17.82,"halted":0,"volume":2081540,"delay":0,"changeRate":0.0045,"floatShares":89225000,"shares":141000000,"eps":0.4183,"marketStatus":"已收盘","change":0.08,"latestTime":"01-06 15:00:00","open":17.78,"high":18.08,"low":17.67,"amount":37264000,"amplitude":0.023,"askPrice":17.91,"askSize":20,"bidPrice":17.9,"bidSize":7,"shortable":0,"etf":0,"ttmEps":0.4183,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767749400000},"marketStatusCode":5,"adr":0,"adjPreClose":17.82,"symbolType":"stock","openAndCloseTimeList":[[1767663000000,1767670200000],[1767675600000,1767682800000]],"highLimit":19.6,"lowLimit":16.04,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":140784675,"isCdr":false,"pbRate":3.45,"roa":"--","peRate":42.792254,"roe":"5.6%","epsLYR":0.3443,"committee":-0.535411,"marketValue":2520000000,"turnoverRate":0.0233,"status":0,"floatMarketCap":1597000000},"requestUrl":"/m/hq/s/301156/wiki","defaultTab":"wiki","newsList":[{"id":"2601824888","title":"美农生物(301156)披露关于变更持续督导保荐代表人的公告,1月5日股价上涨1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601824888","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601824888?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:34","pubTimestamp":1767609284,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,美农生物报收于17.82元,较前一交易日上涨1.77%,最新总市值为25.09亿元。公司于近日发布公告称,上海美农生物科技股份有限公司收到中泰证券出具的关于变更持续督导保荐代表人的报告。由于原保荐代表人陶雪祺先生因工作变动不再负责公司持续督导工作,中泰证券决定委派马骏王先生接替其职务。本次变更后,公司持续督导保荐代表人为嵇志瑶女士和马骏王先生,持续督导期至中国证监会和深交所规定的义务结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500029277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2600706040","title":"每周股票复盘:美农生物(301156)拟每10股派1元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600706040","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600706040?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:02","pubTimestamp":1767384137,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,美农生物报收于17.51元,较上周的17.53元下跌0.11%。本周,美农生物12月30日盘中最高价报17.75元。公司公告汇总上海美农生物科技股份有限公司2025年中期权益分派方案为:以公司总股本140,784,675股为基数,向全体股东每10股派发现金红利1.00元(含税),不送红股,不以资本公积金转增股本。上海美农生物科技股份有限公司投资建设的年产10万吨玉米蛋白精加工项目已取得《饲料生产许可证》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2595720793","title":"美农生物最新公告:股东全裕拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2595720793","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595720793?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:44","pubTimestamp":1767087894,"startTime":"0","endTime":"0","summary":"美农生物(301156.SZ)公告称,持股5%以上股东上海全裕智合管理咨询事务所(有限合伙)因部分合伙人资金需求,计划自公告披露之日起15个交易日后的3个月内,通过集中竞价方式减持公司股份不超过140.78万股,占公司总股本比例不超过1%。减持股份来源为公司首次公开发行前持有及上市后权益分派取得的股份。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000030101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2595738483","title":"美农生物2025年中期拟每10股派现1元,股权登记日为2026年1月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2595738483","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595738483?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:15","pubTimestamp":1767014118,"startTime":"0","endTime":"0","summary":"中访网数据 上海美农生物科技股份有限公司于2025年11月12日召开股东会,审议通过了2025年中期利润分配方案。根据方案,公司将以实施权益分派股权登记日登记的总股本为基数,向全体股东每10股派发现金红利1.00元(含税),本次不进行送股及资本公积金转增股本。本次权益分派的股权登记日确定为2026年1月6日,除权除息日为2026年1月7日,现金红利将于除权除息日通过中国结算深圳分公司划入股东资金账户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251229/31900717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2592956611","title":"美农生物(301156)1388.18万股限售股将于12月17日解禁,占总股本9.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592956611","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592956611?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:12","pubTimestamp":1765930353,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,美农生物于12月17日将有1388.18万股限售股份解禁,为公司追加承诺限售股份上市流通,占公司总股本9.86%。最近一年内,该股累计解禁1096.79万股,占总股本的7.79%。本次解禁后,公司还有5155.97万股限售股份,占总股本36.62%。美农生物主营业务:饲料添加剂和酶解蛋白饲料原料研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700003945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2590168508","title":"美农生物(301156.SZ)超5500万股限售股将解禁,实际可流通约1388万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590168508","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590168508?lang=zh_cn&edition=full","pubTime":"2025-12-12 19:02","pubTimestamp":1765537338,"startTime":"0","endTime":"0","summary":"中访网数据 上海美农生物科技股份有限公司发布公告,部分首次公开发行前已发行的股份即将解除限售并上市流通。本次解除限售的股份涉及股东1户,为控股股东、实际控制人、董事长兼总经理洪伟先生,股份数量为55,527,272股,占公司总股本的39.4413%。因此,本次实际可上市流通的股份数量为13,881,818股,占公司总股本的9.8603%,其余股份将转为高管锁定股。本次解禁后,公司无限售条件流通股将增至89,225,007股,占总股本比例升至63.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251212/31863054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2586202842","title":"美农生物:截至2025年9月30日股东人数合计为10,420户","url":"https://stock-news.laohu8.com/highlight/detail?id=2586202842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586202842?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:21","pubTimestamp":1764318083,"startTime":"0","endTime":"0","summary":"证券之星消息,美农生物(301156)11月28日在投资者关系平台上答复投资者关心的问题。投资者提问:请问10月31日的股东人数是多少,谢谢美农生物回复:尊敬的投资者,您好!为保证投资者获得信息的公平性,公司会根据信息披露相关规则在定期报告中披露相应时点的股东户数信息,公司《2025年三季度报告》披露“截至2025年9月30日的股东人数合计为10,420户”。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800019873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2585988174","title":"美农生物(301156)披露关于变更持续督导保荐代表人的公告,11月24日股价上涨1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585988174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585988174?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:21","pubTimestamp":1763994082,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘,美农生物报收于19.16元,较前一交易日上涨1.38%,最新总市值为26.97亿元。公司于近日发布公告称,上海美农生物科技股份有限公司收到中泰证券通知,因吴彦栋先生工作变动,不再担任公司首次公开发行股票并在创业板上市项目持续督导保荐代表人,由陶雪祺先生接替其职务。变更后,持续督导保荐代表人为嵇志瑶女士和陶雪祺先生,持续督导期至中国证监会和深交所规定结束为止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2585119019","title":"美农生物:公司产品应用于水产养殖领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2585119019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585119019?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:54","pubTimestamp":1763711677,"startTime":"0","endTime":"0","summary":"证券之星消息,美农生物11月21日在投资者关系平台上答复投资者关心的问题。公司专业从事饲料添加剂和酶解蛋白饲料原料研发、生产和销售,公司产品广泛运用于猪、反刍、家禽、水产等动物养殖领域。目前,公司自主创新研发的可应用于水产饲养的产品有肝肠肽保、丁酸类和植物精油等相关产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100018931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2582370194","title":"美农生物(301156)披露2025年中期利润分配方案,11月12日股价下跌0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370194","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370194?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:51","pubTimestamp":1762959078,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,美农生物报收于19.17元,较前一交易日下跌0.83%,最新总市值为26.99亿元。该股当日开盘19.37元,最高19.46元,最低19.1元,成交额达4630.5万元,换手率为3.23%。公司近日发布公告,于2025年11月12日召开2025年第二次临时股东会,审议通过《关于2025年中期利润分配方案的议案》。其中,利润分配方案获得出席会议有效表决权股份的99.9090%同意,反对53,700股,弃权11,300股。中小股东表决结果显示,同意3,076,111股,占出席会议中小股东有效表决权的97.9307%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2581054834","title":"美农生物:探索非粮蛋白原料酶解技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2581054834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581054834?lang=zh_cn&edition=full","pubTime":"2025-11-06 16:33","pubTimestamp":1762417986,"startTime":"0","endTime":"0","summary":"证券之星消息,美农生物11月06日在投资者关系平台上答复投资者关心的问题。多年来,公司不断探索棉籽蛋白、大豆蛋白、玉米蛋白等多种非粮蛋白原料的酶解技术,开发新产品。与传统蛋白原料相比,酶解蛋白原料在蛋白质的消化吸收效率和改善动物生理机能上具有优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600025144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2579916498","title":"美农生物(301156)2025年三季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579916498","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579916498?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:44","pubTimestamp":1761691442,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期美农生物发布2025年三季报。截至本报告期末,公司营业总收入3.9亿元,同比上升14.68%,归母净利润4091.82万元,同比上升29.44%。按单季度数据看,第三季度营业总收入1.54亿元,同比上升16.22%,第三季度归母净利润1739.12万元,同比上升49.67%。本报告期美农生物盈利能力上升,毛利率同比增幅7.26%,净利率同比增幅12.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900010916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156"],"gpt_icon":0},{"id":"2578610415","title":"图解美农生物三季报:第三季度单季净利润同比增长49.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578610415","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578610415?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:05","pubTimestamp":1761563148,"startTime":"0","endTime":"0","summary":"证券之星消息,美农生物2025年三季报显示,公司主营收入3.9亿元,同比上升14.68%;归母净利润4091.82万元,同比上升29.44%;扣非净利润3847.43万元,同比上升39.0%;其中2025年第三季度,公司单季度主营收入1.54亿元,同比上升16.22%;单季度归母净利润1739.12万元,同比上升49.67%;单季度扣非净利润1663.37万元,同比上升57.74%;负债率7.33%,投资收益260.73万元,财务费用-100.39万元,毛利率30.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700029421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156"],"gpt_icon":0},{"id":"2578461627","title":"美农生物(301156)9月30日股东户数1.04万户,较上期减少17.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578461627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578461627?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:16","pubTimestamp":1761556611,"startTime":"0","endTime":"0","summary":"证券之星消息,近日美农生物披露,截至2025年9月30日公司股东户数为1.04万户,较6月30日减少2275.0户,减幅为17.92%。在化学制品行业个股中,美农生物股东户数低于行业平均水平,截至9月30日,化学制品行业平均股东户数为2.71万户。从股价来看,2025年6月30日至2025年9月30日,美农生物区间跌幅为6.51%,在此期间股东户数减少2275.0户,减幅为17.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2577223532","title":"股市必读:10月23日美农生物发布公告,股东减持104.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577223532","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577223532?lang=zh_cn&edition=full","pubTime":"2025-10-24 05:52","pubTimestamp":1761256332,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘,美农生物报收于18.08元,上涨0.44%,换手率2.79%,成交量2.08万手,成交额3728.91万元。股本股东变化股东增减持10月23日美农生物发布公告《美农生物:关于控股股东、实际控制人的一致行动人提前终止减持计划的公告》,其股东上海全裕智合管理咨询事务所于2025年9月10日至2025年10月22日间合计减持104.92万股,占公司目前总股本的0.7452%,变动期间该股股价下跌4.0%,截止10月22日收盘报18.0元。本次减持后,全裕持有股份8,985,619股,占总股本6.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301156","BK0226"],"gpt_icon":0},{"id":"2577372431","title":"美农生物控股股东一致行动人提前终止减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2577372431","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577372431?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:46","pubTimestamp":1761212796,"startTime":"0","endTime":"0","summary":"中访网数据 上海美农生物科技股份有限公司今日公告,公司控股股东、实际控制人的一致行动人上海全裕智合管理咨询事务所决定提前终止其股份减持计划。截至公告披露日,全裕已通过集中竞价方式累计减持公司股份1,407,582股,占公司总股本的0.9998%,减持价格区间为17.00元/股至20.48元/股。经综合考虑,全裕决定提前终止本次减持计划,剩余未减持股份在本次减持计划期限内将不再减持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251023/31731234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2570010481","title":"股市必读:美农生物(301156)9月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570010481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570010481?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:20","pubTimestamp":1758820829,"startTime":"0","endTime":"0","summary":"截至2025年9月25日收盘,美农生物报收于17.51元,下跌1.35%,换手率1.88%,成交量1.4万手,成交额2472.54万元。董秘最新回复投资者: 请问贵公司有没有考虑过,开发动物添加剂疫苗,酶解蛋白疫苗,动物直接注入,不用掺到饲料里,效果一样?公司当前聚焦饲料添加剂和酶解蛋白饲料原料的研发、生产和销售,暂不涉及疫苗的研发、生产和销售。当日关注点来自交易信息汇总:9月25日主力资金净流入106.8万元,显示主力对个股短期态度偏积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600000590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2570647640","title":"美农生物:暂不涉及疫苗研发生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2570647640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570647640?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:33","pubTimestamp":1758789191,"startTime":"0","endTime":"0","summary":"证券之星消息,美农生物09月25日在投资者关系平台上答复投资者关心的问题。公司当前聚焦饲料添加剂和酶解蛋白饲料原料的研发、生产和销售,暂不涉及疫苗的研发、生产和销售。公司将结合产业政策、行业发展趋势、市场与客户需求等,持续迭代升级现有产品,研究开发高效、安全、环保型的饲料添加剂和酶解蛋白饲料原料产品及其应用方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500023874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0226","301156"],"gpt_icon":0},{"id":"2568447019","title":"美农生物:9月17日高管熊英减持股份合计15.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2568447019","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568447019?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:04","pubTimestamp":1758200684,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月18日市场公开信息、上市公司公告及交易所披露数据整理,美农生物最新董监高及相关人员股份变动情况:2025年9月17日公司董事,高管熊英共减持公司股份15.01万股,占公司总股本为0.1066%。变动期间公司股价下跌0.91%,9月17日当日收盘报18.41元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800035838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0},{"id":"2568499235","title":"美农生物:9月16日高管熊英减持股份合计18.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2568499235","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568499235?lang=zh_cn&edition=full","pubTime":"2025-09-17 21:04","pubTimestamp":1758114258,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月17日市场公开信息、上市公司公告及交易所披露数据整理,美农生物最新董监高及相关人员股份变动情况:2025年9月16日公司董事,高管熊英共减持公司股份18.3万股,占公司总股本为0.13%。变动期间公司股价上涨1.25%,9月16日当日收盘报18.58元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700038724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301156"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767710681351,"stockEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":-0.0171},{"period":"3month","weight":0.0091},{"period":"6month","weight":-0.0699},{"period":"1year","weight":0.4597},{"period":"ytd","weight":0.0177}],"compareEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":0.0309},{"period":"3month","weight":0.0362},{"period":"6month","weight":0.1518},{"period":"1year","weight":0.2528},{"period":"ytd","weight":0.0138}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海美农生物科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"10420人(较上一季度减少17.92%)","perCapita":"8562股","listingDate":"2022-06-17","address":"上海市嘉定区沥红路151号","registeredCapital":"14078万元","survey":" 上海美农生物科技股份有限公司的主营业务是饲料添加剂、酶解蛋白饲料原料的研发、生产和销售。公司的主要产品是饲料添加剂、酶解蛋白饲料。上海美农是中国饲料行业协会会员单位、上海市饲料兽行业协会会长单位,持续获得“上海市高新技术企业”“上海市‘专精特新’中小企业”“上海市守合同重信用标杆企业”等荣誉,曾被评为“2020年三十家优秀创新ꞝ饲料企业”“2023年农业产业化嘉定区重点龙头企业”“上海嘉定区农业科技企业”,“美农”商标曾连续多年被评定为“上海市著名商标”。","listedPrice":23.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美农生物(301156)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美农生物(301156)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美农生物,301156,美农生物股票,美农生物股票老虎,美农生物股票老虎国际,美农生物行情,美农生物股票行情,美农生物股价,美农生物股市,美农生物股票价格,美农生物股票交易,美农生物股票购买,美农生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美农生物(301156)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美农生物(301156)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}